Cargando...

Durable response for ampullary and duodenal adenocarcinoma with a nab‐paclitaxel plus gemcitabine ± cisplatin combination

BACKGROUND/AIM: There is no standard salvage chemotherapy for metastatic periampullary adenocarcinoma and duodenal adenocarcinoma and the prognosis of those who fail oxaliplatin, irinotecan, and 5FU is dismal. We examined nanoparticle albumin‐bound paclitaxel (nab‐paclitaxel) as salvage therapy for...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Med
Main Authors: Cen, Putao, Wray, Curtis J., Zhang, Songlin, Thosani, Nirav C., Dinh, Brian Cuong, Gonzalez, Anneliese, Mohlere, Virginia, Bynon, John Steven
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2019
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6601707/
https://ncbi.nlm.nih.gov/pubmed/31102323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2181
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!